within Pharmacolibrary.Drugs.S_SensoryOrgans.S01L_OcularVascularDisorderAgents.S01LA04_Ranibizumab;
model Ranibizumab 
   extends Pharmacolibrary.Drugs.ATC.S.S01LA04;

  annotation(Documentation(
    info ="<html><body><p>Ranibizumab is a recombinant, humanized, monoclonal antibody fragment (Fab) that binds to and inhibits vascular endothelial growth factor A (VEGF-A). It is primarily used for the treatment of neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema, macular edema following retinal vein occlusion, and myopic choroidal neovascularization. Ranibizumab is an approved medication and is widely used in ophthalmology.</p><h4>Pharmacokinetics</h4><p>Reported pharmacokinetic parameters in adult patients with neovascular AMD after intravitreal injection of 0.5 mg ranibizumab.</p><h4>References</h4><ol><li><p>Avery, RL, et al., &amp; Hanley, WD (2017). SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB. <i>Retina (Philadelphia, Pa.)</i> 37(10) 1847–1858. DOI:<a href=&quot;https://doi.org/10.1097/IAE.0000000000001493&quot;>10.1097/IAE.0000000000001493</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28106709/&quot;>https://pubmed.ncbi.nlm.nih.gov/28106709</a></p></li><li><p>Kim, HM, et al., &amp; Woo, SJ (2020). Intraocular Pharmacokinetics of 10-fold Intravitreal Ranibizumab Injection Dose in Rabbits. <i>Translational vision science &amp; technology</i> 9(4) 7–None. DOI:<a href=&quot;https://doi.org/10.1167/tvst.9.4.7&quot;>10.1167/tvst.9.4.7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32818095/&quot;>https://pubmed.ncbi.nlm.nih.gov/32818095</a></p></li><li><p>Bakri, SJ, et al., &amp; Singh, RJ (2007). Pharmacokinetics of intravitreal ranibizumab (Lucentis). <i>Ophthalmology</i> 114(12) 2179–2182. DOI:<a href=&quot;https://doi.org/10.1016/j.ophtha.2007.09.012&quot;>10.1016/j.ophtha.2007.09.012</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18054637/&quot;>https://pubmed.ncbi.nlm.nih.gov/18054637</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Ranibizumab;
